Whole-body FDG-PET can reveal the cause of fevers of unknown origin, according to Dutch researchers.
Whole-body FDG-PET can reveal the cause of fevers of unknown origin, according to Dutch researchers.
Dr. W.J. Oyen, a nuclear physician at Nijmegen Medical Center, and colleagues drew 75 patients from one university and five general community hospitals with fevers of at least 100.4 degrees F that had persisted for at least three weeks. They performed PET after chest x-ray, abdominal ultrasound, and a cryoglobulin blood test failed to identify the fevers' origins.
PET was clinically helpful in 70% of the cases, in which it produced a positive result, and it contributed to the ultimate diagnosis in 33%. Clinicians can boost the efficacy of FDG-PET by excluding patients with a normal erythrocyte sedimentation rate or C-reactive protein. Positive PET findings never arose under those conditions, the researchers said. Oyen reported the findings at the 2006 Society of Nuclear Medicine meeting.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.